Revvity Signals, the software and informatics division of Revvity, has introduced the Signals Clinical solution, a software-as-a-service (SaaS) platform aimed at centralizing complete clinical trial data.
This end-to-end clinical data science platform is designed to accelerate critical trial insights and data-driven decision-making and transform trial data access and analysis.
Such an approach provides rapid, actionable insights, leading to faster clinical decisions and faster delivery of new therapeutics to market.
The integration of Signals Clinical and enterprise-class Spotfire visual analytics will redefine data processing in the pharmaceutical, biotech, and contract research industries.
The platform provides access and insights to accelerate clinical development and therapeutic innovation.
This product facilitates self-service access to integrated clinical trial data by centralizing all clinical development data in one place.
Access the most comprehensive company profiles on the market with GlobalData. Save research time. Increase competitiveness.
Company Profile – Free Sample
You will receive a download email shortly
We are confident in the unique quality of our company profile. However, we want you to make the decision that is most beneficial for your business, so we are offering free samples that you can download by submitting the form below.
by global data
This centralization facilitates a complete overview of patient safety, treatment efficacy, and trial progress.
Using Signals Clinical in conjunction with Spotfire simplifies data preparation and improves delivery of assessments such as safety, efficacy, and cross-study analyses.
This reduction in manual data processing allows organizations to focus on delivering critical trial insights and strengthen cross-functional partnerships.
The platform also provides customizable workflows for data management, clinical review monitoring of trials, and integrated partnership tools.
These characteristics help research managers document and reference queries, improving partnerships and increasing the efficiency of clinical research teams.
said Kevin Willoe, Senior Vice President and General Manager, Revvity Signals Software. “Signals Clinical is our answer to the industry’s urgent need for a solution that is not only designed to protect patient safety, but also enables data-driven decision-making with near real-time analytics.
“By integrating this platform with advanced data visualization tools, we will enable our customers to more easily and efficiently navigate the complexities of clinical development, thereby accelerating the delivery of new medicines to patients. ”
